{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:52:02Z","timestamp":1775929922737,"version":"3.50.1"},"posted":{"date-parts":[[2025,2,20]]},"group-title":"Cell Biology","reference-count":67,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Regardless of the source of injury or metabolic dysfunction, fibrosis is a frequent driver of liver pathology. Excessive liver fibrosis is caused by persistent activation of hepatic stellate cells (HSCs), which is defined by myofibroblast activation (MFA) and the epithelial-mesenchymal transition (EMT). Strategies to prevent or reverse this HSC phenotype will be critical for successful treatment of liver fibrosis. We have previously shown that full-term, cell-free human amniotic fluid (cfAF) inhibits MFA and EMT in fibroblasts\n                  <jats:italic>in vitro<\/jats:italic>\n                  . We hypothesize that cfAF treatment can attenuate HSC activation and limit liver fibrosis. We tested if cfAF could prevent liver fibrosis or HSC activation in murine models of liver damage, three-dimensional hepatic spheroids, and HSC cultures. Administering cfAF prevented weight loss and the extent of fibrosis in mice with chronic liver damage without stimulating deleterious immune responses. Gene expression profiling and immunostaining indicated that cfAF administration in carbon tetrachloride-treated mice reduced EMT- and MFA-related biomarker abundance and modulated transcript levels associated with liver metabolism, immune regulatory pathways, and cell signaling. cfAF treatment lowered MFA biomarker levels in a dose-dependent manner in\n                  <jats:italic>ex vivo<\/jats:italic>\n                  hepatic spheroids. Treating HSCs with cfAF\n                  <jats:italic>in vitro<\/jats:italic>\n                  strongly repressed EMT. Multi-omics analyses revealed that it also attenuates TGF\u03b2-induced MFA and inflammation-associated processes. Thus, cfAF treatment prevents liver fibrosis by safeguarding against persistent HSC activation. These findings suggest that cfAF may be a safe and effective therapy for reducing liver fibrosis and preventing the development of cirrhosis and\/or hepatocellular carcinoma.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Significance<\/jats:title>\n                  <jats:p>Chronic activation of hepatic stellate cells leads to irreversible liver fibrosis, and durable treatment options for liver fibrosis remain suboptimal, creating a critical clinical need. Amniotic fluid (AF) reduces inflammation and promotes tissue remodeling and regeneration when applied to cutaneous wounds and in models thereof. However, no prior studies have explored the anti-fibrotic benefits of AF in liver disease. Data from this study indicate that AF can repress liver fibrosis by reducing pro-fibrotic hepatic stellate cell myofibroblast activation. Thus, these findings lay the foundation for early-phase clinical trials investigating cell-free AF as a therapeutic treatment for liver fibrosis and as a bridging therapy for liver transplantation.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.02.20.639215","type":"posted-content","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:55:49Z","timestamp":1740110149000},"source":"Crossref","is-referenced-by-count":0,"title":["Amniotic Fluid Reduces Liver Fibrosis By Attenuating Hepatic Stellate Cell Activation"],"prefix":"10.64898","author":[{"given":"Charles M.","family":"Bowen","sequence":"first","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch, Galveston, Texas, 77555, USA"},{"name":"John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Ditmars","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch, Galveston, Texas, 77555, USA"},{"name":"John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiyou","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Marri","family":"Abril","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch, Galveston, Texas, 77555, USA"},{"name":"John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ajasin","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Cell Biology, and Anatomy, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K.","family":"Russell","sequence":"additional","affiliation":[{"name":"Deparment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-7621","authenticated-orcid":false,"given":"Heather L.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliseo A.","family":"Eugenin","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Cell Biology, and Anatomy, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Fair","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch, Galveston, Texas, 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2909-1666","authenticated-orcid":false,"given":"W. Samuel","family":"Fagg","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch, Galveston, Texas, 77555, USA"},{"name":"Deparment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, 77555, USA"},{"name":"Merakris Therapeutics, RTP Frontier, Research Triangle Park, North Carolina, 27709, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026041110403440000_2025.02.20.639215v2.1","unstructured":"Chen, Chiung & Yoon, Young-Hee . LIVER CIRRHOSIS MORTALITY IN THE UNITED STATES: NATIONAL, STATE, AND REGIONAL TRENDS, 2000\u20132019. Surveill. Rep. (2022)."},{"key":"2026041110403440000_2025.02.20.639215v2.2","first-page":"e201997","article-title":"Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw","volume":"3","year":"2020","journal-title":"Open"},{"key":"2026041110403440000_2025.02.20.639215v2.3","first-page":"1920","article-title":"Financial Burden in Adults with Chronic Liver Disease: A Scoping Review","volume":"28","year":"2022","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc"},{"key":"2026041110403440000_2025.02.20.639215v2.4","doi-asserted-by":"crossref","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J. Clin. Invest. 127, 55\u201364.","DOI":"10.1172\/JCI88881"},{"key":"2026041110403440000_2025.02.20.639215v2.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.07002.x"},{"key":"2026041110403440000_2025.02.20.639215v2.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27332"},{"key":"2026041110403440000_2025.02.20.639215v2.7","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.914246"},{"key":"2026041110403440000_2025.02.20.639215v2.8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28812"},{"key":"2026041110403440000_2025.02.20.639215v2.9","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040875"},{"key":"2026041110403440000_2025.02.20.639215v2.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06602-z"},{"key":"2026041110403440000_2025.02.20.639215v2.11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23196"},{"key":"2026041110403440000_2025.02.20.639215v2.12","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-018-0097-4"},{"key":"2026041110403440000_2025.02.20.639215v2.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316958"},{"key":"2026041110403440000_2025.02.20.639215v2.14","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.3390\/biomedicines10112960","article-title":"Cell-Free Amniotic Fluid and Regenerative Medicine: Current Applications and Future Opportunities","volume":"10","year":"2022","journal-title":"Biomedicines"},{"key":"2026041110403440000_2025.02.20.639215v2.15","unstructured":"Fetal Physiology - ClinicalKey. https:\/\/www.clinicalkey.com\/#!\/content\/book\/3-s2.0-B9780323566889000053."},{"key":"2026041110403440000_2025.02.20.639215v2.16","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-015-0557-3"},{"key":"2026041110403440000_2025.02.20.639215v2.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2006.11.009"},{"key":"2026041110403440000_2025.02.20.639215v2.18","unstructured":"Fitzsimmons, E. D. & Bajaj, T . Embryology, Amniotic Fluid. in StatPearls (StatPearls Publishing, Treasure Island (FL), 2022)."},{"key":"2026041110403440000_2025.02.20.639215v2.19","doi-asserted-by":"publisher","DOI":"10.1007\/s10561-016-9572-7"},{"key":"2026041110403440000_2025.02.20.639215v2.20","doi-asserted-by":"crossref","first-page":"2050313X221100882","DOI":"10.1177\/2050313X221100882","article-title":"Safety and efficacy of acellular human amniotic fluid and membrane in the treatment of non-healing wounds in a patient with chronic venous insufficiency","volume":"10","year":"2022","journal-title":"SAGE Open Med. Case Rep"},{"key":"2026041110403440000_2025.02.20.639215v2.21","first-page":"443","article-title":"Cryopreserved Amniotic Suspension for the Treatment of Knee Osteoarthritis","volume":"29","year":"2016","journal-title":"J. Knee Surg"},{"key":"2026041110403440000_2025.02.20.639215v2.22","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.arthro.2021.02.044","article-title":"Safety and Efficacy of an Amniotic Suspension Allograft Injection Over 12 Months in a Single-Blinded, Randomized Controlled Trial for Symptomatic Osteoarthritis of the Knee","volume":"37","year":"2021","journal-title":"Arthrosc. J. Arthrosc. Relat. Surg. Off. Publ. Arthrosc. Assoc. N. Am. Int. Arthrosc. Assoc"},{"key":"2026041110403440000_2025.02.20.639215v2.23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.arthro.2021.04.034","article-title":"A Single Injection of Amniotic Suspension Allograft Is Safe and Effective for Treatment of Mild to Moderate Hip Osteoarthritis: A Prospective Study","volume":"38","year":"2022","journal-title":"Arthrosc. J. Arthrosc. Relat. Surg. Off. Publ. Arthrosc. Assoc. N. Am. Int. Arthrosc. Assoc"},{"key":"2026041110403440000_2025.02.20.639215v2.24","first-page":"404","article-title":"Allogenic Amniotic Tissue for Treatment of Knee and Hip Osteoarthritis","volume":"15","year":"2022","journal-title":"Pharm. Basel Switz"},{"key":"2026041110403440000_2025.02.20.639215v2.25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.583842"},{"key":"2026041110403440000_2025.02.20.639215v2.26","first-page":"101502","article-title":"Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic","volume":"34","year":"2021","journal-title":"Respir. Med. Case Rep"},{"key":"2026041110403440000_2025.02.20.639215v2.27","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3390\/biomedicines10092189","article-title":"Comparative Analysis of Co-Cultured Amniotic Cell-Conditioned Media with Cell-Free Amniotic Fluid Reveals Differential Effects on Epithelial\u2013Mesenchymal Transition and Myofibroblast Activation","volume":"10","year":"2022","journal-title":"Biomedicines"},{"key":"2026041110403440000_2025.02.20.639215v2.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-019-0160-8"},{"key":"2026041110403440000_2025.02.20.639215v2.29","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.042127"},{"key":"2026041110403440000_2025.02.20.639215v2.30","doi-asserted-by":"publisher","DOI":"10.1007\/BF02723678"},{"key":"2026041110403440000_2025.02.20.639215v2.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2005.00103.x"},{"key":"2026041110403440000_2025.02.20.639215v2.32","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.IMA03BS111"},{"key":"2026041110403440000_2025.02.20.639215v2.33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac327"},{"key":"2026041110403440000_2025.02.20.639215v2.34","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.09.617384"},{"key":"2026041110403440000_2025.02.20.639215v2.35","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"2026041110403440000_2025.02.20.639215v2.36","doi-asserted-by":"publisher","DOI":"10.1101\/2023.04.04.535623"},{"key":"2026041110403440000_2025.02.20.639215v2.37","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2026041110403440000_2025.02.20.639215v2.38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41597-023-02537-w","article-title":"A large-scale LC-MS dataset of murine liver proteome from time course of heavy water metabolic labeling","volume":"10","year":"2023","journal-title":"Sci. Data"},{"key":"2026041110403440000_2025.02.20.639215v2.39","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2377"},{"key":"2026041110403440000_2025.02.20.639215v2.40","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4256"},{"key":"2026041110403440000_2025.02.20.639215v2.41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249364"},{"key":"2026041110403440000_2025.02.20.639215v2.42","doi-asserted-by":"publisher","DOI":"10.1177\/0023677215571192"},{"key":"2026041110403440000_2025.02.20.639215v2.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72801-1"},{"key":"2026041110403440000_2025.02.20.639215v2.44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-10-79"},{"key":"2026041110403440000_2025.02.20.639215v2.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30582-3"},{"key":"2026041110403440000_2025.02.20.639215v2.46","doi-asserted-by":"publisher","DOI":"10.1177\/0023677215570086"},{"key":"2026041110403440000_2025.02.20.639215v2.47","doi-asserted-by":"crossref","unstructured":"Bao, Y. et al. Animal and Organoid Models of Liver Fibrosis. Front. Physiol. 12, (2021).","DOI":"10.3389\/fphys.2021.666138"},{"key":"2026041110403440000_2025.02.20.639215v2.48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112871"},{"key":"2026041110403440000_2025.02.20.639215v2.49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119662"},{"key":"2026041110403440000_2025.02.20.639215v2.50","first-page":"100958","article-title":"Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis","volume":"6","year":"2023","journal-title":"JHEP Rep"},{"key":"2026041110403440000_2025.02.20.639215v2.51","doi-asserted-by":"publisher","DOI":"10.1038\/srep25187"},{"key":"2026041110403440000_2025.02.20.639215v2.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109393"},{"key":"2026041110403440000_2025.02.20.639215v2.53","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06774-3"},{"key":"2026041110403440000_2025.02.20.639215v2.54","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2026041110403440000_2025.02.20.639215v2.55","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-008-2180-y"},{"key":"2026041110403440000_2025.02.20.639215v2.56","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05289-6"},{"key":"2026041110403440000_2025.02.20.639215v2.57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2026041110403440000_2025.02.20.639215v2.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.039"},{"key":"2026041110403440000_2025.02.20.639215v2.59","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.009"},{"key":"2026041110403440000_2025.02.20.639215v2.60","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-306842"},{"key":"2026041110403440000_2025.02.20.639215v2.61","doi-asserted-by":"publisher","DOI":"10.1038\/nri3623"},{"key":"2026041110403440000_2025.02.20.639215v2.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0125-y"},{"key":"2026041110403440000_2025.02.20.639215v2.63","doi-asserted-by":"crossref","unstructured":"Alhomrani, M. et al. The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis. Front. Pharmacol. 8, (2017).","DOI":"10.3389\/fphar.2017.00748"},{"key":"2026041110403440000_2025.02.20.639215v2.64","doi-asserted-by":"publisher","DOI":"10.3390\/cells12162114"},{"key":"2026041110403440000_2025.02.20.639215v2.65","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00073"},{"key":"2026041110403440000_2025.02.20.639215v2.66","doi-asserted-by":"publisher","DOI":"10.1177\/1933719113518987"},{"key":"2026041110403440000_2025.02.20.639215v2.67","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1011"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.02.20.639215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:40:43Z","timestamp":1775929243000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.02.20.639215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":67,"URL":"https:\/\/doi.org\/10.1101\/2025.02.20.639215","relation":{},"subject":[],"published":{"date-parts":[[2025,2,20]]},"subtype":"preprint"}}